Moderna hails successful trial of combined Covid and flu shot
Vaccine maker to seek approval for jab as it tries to diversify product pipeline
Moderna
Moderna reports surprise profit and sets out plan for RSV vaccine
Focus on new treatments as Covid vaccine sales fell from $18.4 billion in 2022 to $6.8 billion last year
Moderna shares hit by quarterly loss and waning Covid vaccine demand
Biotech blames weaker US sales after lowering full-year forecast
FDA approves new Covid boosters as cases rise around US
Hospitalisations from Covid-19 have crept up in recent weeks, although the rise is lower than the same time last year
Cancer vaccine research has reached turning point, experts say
Researchers believe personalised medicine and vaccines are probably the next big thing in the quest to reduce cancer deaths
US bosses enjoyed big pay rises in 2022 despite falling stock market
Chief executive of Simon Property Group saw pay more than triple last year to $35.4m even as shareholder return dropped by 22%
BioNTech/Pfizer’s mooted EU deal for 70m Covid shots threatens rivals
European health officials have advocated portfolio diversity to help fight different variants
Unused Covid-19 vaccines worth €95m discarded by HSE last year
More than 850,000 doses of past-expiry date Covid-19 vaccines thrown out
Global markets rally as traders expect interest rates to peak soon
Dublin market outperforms international peers as it finishes the day up 1.7% on the back of strong rallies
Irish software company Workhuman to cut about 10% of global workforce
Workhuman, which specialises in employee reward and incentive programmes for companies worldwide, employs 600 people in Ireland
Shine comes off vaccine stocks
Novavax had a terrible week while Pfizer and Moderna are well off their pandemic highs
Vaccine maker Novavax tumbles after warning of ‘substantial doubt’ over future
Manufacturing woes meant it lost out in race to market with its Covid vaccine
Moderna’s mRNA cancer vaccine shows promise in early trial
Study suggests combination with Merck immunotherapy drug reduces risk of death in high-risk patients
Biontech sees some vaccine deliveries shifting to next year
Sales drop 43% in third quarter as primary immunisation drives reach completion
Vaccine makers face revenue slump as demand falls for Covid-19 jabs
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
Investors ditch vaccine stocks after Joe Biden says ‘pandemic is over’
Top jab makers lose combined $10bn of market value amid fears over growing public apathy
US FDA authorises two Covid boosters targeted at Omicron subvariants
Vaccines also include original version of virus
Moderna accuses BioNTech/Pfizer of copying mRNA technology
US biotech claims rival Covid vaccine makers infringed patents underpinning jabs
The story of a vaccine: how Moderna’s big bet played out
New book details how talent, leaps of faith and dogged determination brought the pharma company to world attention in 2020
Covid vaccines for children under-5 cleared by US health officials
President hails ‘monumental step forward’ in battle against virus but parents have been more cautious in inoculating children
Pfizer to seek approval of Covid vaccine for under 5s
Interim results from its clinical trial showed the jab is safe and highly effective, company said
Irish Open golf sponsorship a calling card for careers in curing rare diseases
Interview: Horizon Therapeutics chief Tim Walbert sees Dublin at heart of its international expansion
Covid-stopping nasal spray: The silver bullet we’ve been waiting for?
With the virus rampant despite jabs, trials are underway to create intranasal vaccines
‘Stay vigilant’: no let-up in North Korea’s two-year Covid lockout
Pyongyang says it has kept its population Covid-free by sealing the country’s borders
EU’s Digital Covid certificate scheme to be extended until June 2023
Adoption of committee reports confirms extension intended to facilitate travel
Pandemic wind-down reveals vaccine winners
Cantillon: Emerging markets surprise observers with vaccine preferences
Pfizer and Moderna urged to share vaccine technology with developing world
Proxy advisers back shareholder resolutions as new shot shows promising results
Chief executives of mRNA vaccine groups earn $100m in pandemic pay
Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge
Grammy awards 2022: Olivia Rodrigo and Silk Sonic triumph
Ukraine’s president Zelenskiy makes cameo at scandal free ceremony after Oscars chaos
Moderna seeks FDA authorisation for second Covid booster
Request is significantly broader than Pfizer and its German partner BioNTech’s
AstraZeneca prepared to ditch effort to secure US approval for Covid vaccine
‘We don’t need to push it in places we are not needed or wanted,’ says drugmaker’s VP
Got a Covid booster jab? You probably won’t need another for a while
Three doses can protect against serious illness and death for a long time, studies suggest
Covid-19: 460 reports of menstrual disturbance from vaccinated
European Medicines Agency says no evidence to suggest vaccines affect fertility
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices